Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production

Cancer Letters

Volumn 147, Issue 1-2, 1999, Pages 215-219

  Yamada, Yasuaki ^a   Sugahara, Kazuyuki ^a   Tsuruda, Kazuto ^a   Nohda, Kazuo ^a   Hata, Tomoko ^b   Maeda, Takahiro ^b   Honda, Miyuki ^b   Tawara, Masayuki ^b   Hayashibara, Toshihisa ^b   Joh, Tatsuroh ^b   Tomonaga, Masao ^b   Miyazaki, Yoshitsugu ^a   Kamihira, Shimeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Adult T cell leukemia; Apoptosis; Fas; Fas associated phosphatase 1; Human T cell leukemia virus type I

Indexed keywords

FAS ANTIGEN; PHOSPHATASE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL CLONE; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; T CELL LEUKEMIA;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; BLOTTING, SOUTHERN; CARRIER PROTEINS; CLONE CELLS; DNA FRAGMENTATION; DNA, COMPLEMENTARY; DRUG RESISTANCE, NEOPLASM; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA, T-CELL; PROTEIN-TYROSINE-PHOSPHATASE; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; VIRUS INTEGRATION;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0032750977     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00313-4     Document Type: Article

References (24)

1. Trauth B.C., Klas C., Peters A.M., Matzku S., Moller P., Falk W., Debatin K.M., Krammer P.H. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science. 245:1989;301-305.
2. Yohehara S., Ishii A., Yonehara M. cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1989;1747-1756.
3. Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hase A., Seto Y., Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66:1991;233-243.
4. Nagata S., Goldstein P. The Fas death factor. Science. 267:1995;1449-1456.
5. Uchiyama T., Yodoi J., Sagawa K., Takatsuki K., Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 50:1977;481-492.
6. Yamada Y. Phenotypic and functional analysis of leukemic cells from 16 patients with adult T-cell leukemia/lymphoma. Blood. 61:1983;192-199.
7. Poiesz B.J., Ruscetti F.W., Gazdor A.F., Bunn P.A., Minna J.D., Gallo R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patients with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA. 77:1980;7415-7419.
8. Yoshida M., Miyoshi I., Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. USA. 79:1982;2031-2035.
9. Arai M., Kannagi M., Matsuoka M., Sato T., Yamamoto N., Fujii M. Expression of FAP-1 (Fas-associated phosphatase) and resistance to Fas-mediated apoptosis in T cell lines derived from human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients. AIDS Res. Hum. Retrov. 14:1998;261-267.
10. Yamada Y., Fujita M., Suzuki H., Atogami S., Sohda H., Murata K., Tsukasaki K., Momita S., Kohno T., Maeda T., Joh T., Kamihira S., Shiku M. Established IL-2-dependent double-negative (CD4-/CD8-) TCRαβ/CD3+ ATL cells: induction of CD4 expression. Br. J. Haematol. 88:1994;234-241.
11. Hata T., Fujimoto T., Tsushima H., Murata K., Tsukasaki K., Atogami S., Sohda H., Honda S., Mine M., Yamada Y., Ikeda S., Kamihira S., Tomonaga M. Multi-clonal expansion of unique human T-lymphotropic virus type-1-infected T cells with high growth potential in response to interleukin-2 in prodromal phase of adult T cell leukemia. Leukemia. 13:1999;215-221.
12. Yamada Y., Nagata Y., Kamihira S., Tagawa M., Ichimaru M., Tomonaga M., Shiku H. IL-2-dependent ATL cell lines with phenotypes differing from the original leukemia cells. Leukemia Res. 15:1991;619-625.
13. Posner L.E., Robert-Guroff M., Kalyanaraman V.S., Poiesz B.J., Ruscetti F.W., Fossieck B., Bunn P.A. Jr., Minna J.D., Gallo R.C. Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas. J. Exp. Med. 154:1981;333-346.
14. Ungefroren H.M., Voss M., Jansen M., Roeder C., Henne-Bruns D., Kremer B., Kalthoff H. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res. 58:1998;1741-1749.
15. Yamada Y., Sugahara K., Hata T., Tsuruda K., Moriuchi R., Maeda T., Atogami S., Murata K., Fujimoto K., Kohno T., Tsukasaki K., Tomonaga M., Hirakata Y., Kamihira S. Interleukin-15 (IL-15) can replace the IL-2 signal in IL-2-dependent adult T-cell leukemia (ATL) cell lines: expression of IL-15 receptorα on ATL cells. Blood. 91:1998;4265-4272.
16. Brauweiler A., Garrus J.E., Reed J.C., Nyborg J.K. Repression of bax gene expression by the HTLV-1 tax protein: implications for suppression of apoptosis in virally infected cells. Virology. 231:1997;135-140.
17. Mulloy J.C., Kislyakova T., Cereseto A., Casareto L., LoMonico A., Fullen J., Lorenzi M.V., Cara A., Nicot C., Giam C., Franchini G. Human T-cell lymphotropic/leukemia virus type 1 Tax abrogated p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain. J. Virol. 72:1998;8852-8860.
18. Sato T., Irie S., Kitada S., Reed J.C. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science. 268:1995;411-415.
19. Vaux D.L., Cory S., Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335:1988;440-442.
20. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
21. Cheng J., Zhou T., Liu C., Shapiro J.P., Brauer M.J., Kiefer M.C., Barr P.J., Mountz J.P. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 263:1994;1759-1762.
22. Sugahara K., Yamada Y., Hirakata Y., Matsuo Y., Tsuruda K., Tomonaga M., Maeda T., Atogami S., Tsukasaki K., Kamihira S. Soluble and membrane isoforms of Fas/CD95 in fresh adult T-cell leukemia (ATL) cells and ATL-cell lines. Int. J. Cancer. 72:1997;128-132.
23. Landowski T.H., Gleason-Guzman M.C., Dalton W.S. Selection for drug resistance results in resistance to Fas-mediated apoptosis. Blood. 89:1997;1854-1861.
24. Los M., Herr I., Friesen C., Fulda S., Schulze-Osthoff K., Debatin K.M. Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases). Blood. 90:1997;3118-3129.